Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases [Phase 1]

View source ↗

Summary

BeiGene is conducting a Phase 1 trial to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of single- and multiple-ascending doses of BGB-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Prurigo Nodularis

Drugs mentioned

• BGB-45035

Snippet

Sponsor: BeiGene | Conditions: Healthy Participants, Healthy Subjects | Phase 1 | Status: RECRUITING